$NNNN

Anbio Biotechnology

Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Frankfurt Am Main, Germany

Charts by TradingView

NNNN chart

What traders are saying about $NNNN

Latest posts

Anbio Biotechnology news

Anbio Biotechnology key financials

USD2025202420232022
Revenue$8.6M$8.2M$6.7M$23.5M
Net income$6.4M$2.4M$2.3M$10.0M
Diluted EPS$0.15$0.06$0.10$100112.00
Total assets (year end)$30.2M$18.9M$15.8M–
Cash and equivalents (year end)$7.8M$11.8M$9.7M–

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Anbio Biotechnology

Ticker
NNNN (Nasdaq)
Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Frankfurt Am Main, Germany
Incorporated in
Cayman Islands
Fiscal year end
December 31
SEC CIK
1982708

Frequently asked questions

What exchange is Anbio Biotechnology listed on?

Anbio Biotechnology trades on the Nasdaq under the ticker symbol NNNN.

What industry is Anbio Biotechnology in?

Anbio Biotechnology is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.

Where is Anbio Biotechnology headquartered?

Anbio Biotechnology's business address on file with the SEC is in Frankfurt Am Main, Germany.

When does Anbio Biotechnology's fiscal year end?

Anbio Biotechnology's fiscal year ends on December 31.

How much revenue did Anbio Biotechnology report?

Anbio Biotechnology reported $8.6M in revenue for calendar year 2025, according to its SEC filings.